This study is a prospective and randomized single-blind clinical trial. The aim of this study is to compare the effect of vitamin D3 with 2 different doses on metabolic disorders in women with polycystic ovary syndrome and vitamin D deficiency. Total of sample size is 124 woman with ages: 18-45 years old. The patients with malabsorption, chronic renal failure, cirrhosis, pancreatitis, nephrotic syndrome, cancer, hyperprolactinemia, cushing's syndrome, congenital adrenal hyperplasia, androgen secreting tumors and pregnant and lactating patients will be excluded. The patients are randomly divided into two groups. Patients do not know about the protocol of the study and type of drug. First group receives oral dose of 50,000 IU of vitamin D once per week for 8 weeks. Second group receives oral dose of 50,000 IU of vitamin D once per month for 2 months. In both methods, 1000 mg of calcium carbonate are given twice daily throughout the treatment period. Patients basic information such as age and BMI, serum triglyceride, LDL, HDL, total cholesterol, fasting blood sugar, fasting insulin levels, vitamin D will be recorded in both groups before treatment and after the treatment period.